000163387 001__ 163387
000163387 005__ 20230915090517.0
000163387 0247_ $$2doi$$a10.3389/fneur.2022.813282
000163387 0247_ $$2pmid$$apmid:35250820
000163387 0247_ $$2pmc$$apmc:PMC8894665
000163387 0247_ $$2altmetric$$aaltmetric:123297679
000163387 037__ $$aDZNE-2022-00149
000163387 041__ $$aEnglish
000163387 082__ $$a610
000163387 1001_ $$aPignolo, Loris$$b0
000163387 245__ $$aROBOCOP (ROBOtic Care of Poststroke Pain): Study Protocol for a Randomized Trial to Assess Robot-Assisted Functional and Motor Recovery and Impact on Poststroke Pain Development.
000163387 260__ $$aLausanne$$bFrontiers Research Foundation$$c2022
000163387 3367_ $$2DRIVER$$aarticle
000163387 3367_ $$2DataCite$$aOutput Types/Journal article
000163387 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1654866169_23356
000163387 3367_ $$2BibTeX$$aARTICLE
000163387 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000163387 3367_ $$00$$2EndNote$$aJournal Article
000163387 520__ $$aStroke is one of the most frequent causes of death and disability worldwide. It is accompanied by the impaired motor function of the upper extremities in over 69% of patients up to hemiplegia in the following 5 years in 56% of cases. This condition often is characterized by chronic poststroke pain, difficult to manage, further worsening quality of life. Poststroke pain occurs within 3-6 months. Robot-assisted neurorehabilitation using the Automatic Recovery Arm Motility Integrated System (ARAMIS) has proven efficacy in motor function recovery exploiting the movements and the strength of the unaffected arm. The rationale of the ROBOCOP (ROBOtic Care of Poststroke pain) randomized trial is the assessment of the impact of robot-assisted functional and motor recovery on the prevention of poststroke pain.A total of 118 patients with hemiplegic arms due to stroke will be enrolled and randomly allocated with a 1:1 ratio to ARAMIS or conventional neurorehabilitation group. After a baseline screening at hospital discharge, ARAMIS or conventional rehabilitation will be performed for 8 weeks. The primary endpoint is the prevention of the development of poststroke pain and the secondary endpoints are prevention of spasticity and efficacy in clinical motor rehabilitation. The primary outcome measures consist in the visual analog scale and the doleur neuropatique 4 and the secondary outcome measures include: the Modified Ashworth Scale, the Resistance to Passive movement Scale; the Upper Extremity Subscale of the Fugl-Meyer Motor Assessment; the Action Research Arm Test; the Barthel Index for activities of daily living; and the magnetic resonance imaging (MRI) recovery-related parameters. After baseline, both primary and secondary outcome measures will be performed in the following time points: 1 month after stroke (t 1, half of the rehabilitation); 2 months after stroke (t 2, after rehabilitation); and 3 months (t 3) and 6 months (t 4) after stroke, critical for poststroke pain development.This is the first clinical trial investigating the efficacy of robot-assisted neurorehabilitation using ARAMIS on poststroke pain prevention. This study could remarkably improve the quality of life of stroke survivors.
000163387 536__ $$0G:(DE-HGF)POF4-351$$a351 - Brain Function (POF4-351)$$cPOF4-351$$fPOF IV$$x0
000163387 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000163387 650_7 $$2Other$$aARAMIS
000163387 650_7 $$2Other$$amotor rehabilitation
000163387 650_7 $$2Other$$apost-stroke pain
000163387 650_7 $$2Other$$arobot-assisted neurorehabilitation
000163387 650_7 $$2Other$$astroke recovery
000163387 7001_ $$aTonin, Paolo$$b1
000163387 7001_ $$0P:(DE-2719)2010732$$aNicotera, Pierluigi$$b2$$udzne
000163387 7001_ $$aBagetta, Giacinto$$b3
000163387 7001_ $$aScuteri, Damiana$$b4
000163387 773__ $$0PERI:(DE-600)2564214-5$$a10.3389/fneur.2022.813282$$gVol. 13, p. 813282$$p813282$$tFrontiers in neurology$$v13$$x1664-2295$$y2022
000163387 8564_ $$uhttps://pub.dzne.de/record/163387/files/DZNE-2022-00149.pdf$$yOpenAccess
000163387 8564_ $$uhttps://pub.dzne.de/record/163387/files/DZNE-2022-00149.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000163387 909CO $$ooai:pub.dzne.de:163387$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000163387 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2010732$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000163387 9131_ $$0G:(DE-HGF)POF4-351$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vBrain Function$$x0
000163387 9141_ $$y2022
000163387 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2021-01-28
000163387 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-28
000163387 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-28
000163387 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-01-28
000163387 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000163387 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-01-28
000163387 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT NEUROL : 2021$$d2022-11-18
000163387 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-18
000163387 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-18
000163387 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-05-11T13:11:28Z
000163387 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-05-11T13:11:28Z
000163387 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-05-11T13:11:28Z
000163387 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-18
000163387 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-18
000163387 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-18
000163387 9201_ $$0I:(DE-2719)1013003$$kAG Bano$$lAging and neurodegeneration$$x0
000163387 9201_ $$0I:(DE-2719)1030000$$kScientific board$$lScientific board$$x1
000163387 980__ $$ajournal
000163387 980__ $$aVDB
000163387 980__ $$aUNRESTRICTED
000163387 980__ $$aI:(DE-2719)1013003
000163387 980__ $$aI:(DE-2719)1030000
000163387 9801_ $$aFullTexts